• pathology@iaioncology.org

3rd International Conference on
Oncopathology & Molecular Oncology

17th & 18th November - 2025 | Virtual

Connect with global experts, discover innovations, and shape the future of oncopathology and molecular oncology together.

Organized by

Welcome to 3rd International Oncopathology & Molecular Oncology

The International Association for Integrated Oncology (IAIO) is organizing the 3rd International Conference on Oncopathology & Molecular Oncology, scheduled to be held virtually on November 17–18, 2025. This highly anticipated event is designed to bring together leading researchers, clinicians, pathologists, oncologists, and molecular scientists from across the globe to exchange knowledge, share breakthroughs, and discuss the latest advancements in oncopathology and molecular oncology. With an emphasis on multidisciplinary collaboration, the conference serves as a dynamic platform for exploring novel diagnostic tools, targeted therapies, and precision medicine approaches that are reshaping cancer care.
Participants can look forward to expert-led sessions, panel discussions, and interactive forums that delve into current trends and future directions in cancer biology and personalized medicine. The 3rd edition of this conference not only highlights the critical role of molecular and pathological insights in oncology but also reinforces IAIO’s commitment to building a global community united in the fight against cancer.

Our Committee Members

Program Director

Dr. Andres M. Acosta,

Indiana University,
USA

Organizing Secretary

Dr. Ankur Sangoi,

Stanford Medicine,
USA

Our Faculties

Dr. Justin Sims,

Indiana University,
USA

Dr. Francesca Khani,

Weill Cornell Medicine,
USA.

Dr. Quoc-Dien Trinh,

University of Pittsburgh Medical Center,
USA

Dr. Nabil Adra,

Indiana University Simon Comprehensive Cancer Center,
USA

Dr. Sean Williamson,

Cleveland Clinic,
USA

Dr. Heather Huelster,

Indiana University,
USA

Dr. Alice Fan,

Stanford University,
USA

Objectives of 3rd Oncopathology & Molecular Oncology

The conference aims to enhance understanding of Oncpathology & Molecular Oncology, especially in prostate and renal cancers, through multidisciplinary perspectives, focusing on diagnostic advances, surgical strategies, molecular profiling, and therapeutic innovations to improve patient outcomes.

Technological Advancements in Cancer Diagnosis

Delve into emerging technologies that are enhancing the accuracy and efficiency of cancer diagnostic methodologies.

Integration of Pathology and Molecular Studies

Learn the structured incorporation of histopathological analysis alongside molecular profiling to facilitate a thorough and comprehensive oncologic evaluation.

Patient-Centered Precision Oncology

Advance the implementation of personalized oncology approaches informed by molecular characteristics and individual patient profiles.

Facilitate Global Collaboration and Networking

International collaboration and academic exchange to strengthen multidisciplinary efforts in cancer research and care.

Encourage Translational Research and Clinical Implementation

Seamless translation of research findings into clinical practice to improve cancer diagnosis, treatment, and patient outcomes.

Scope of the Conference

The 3rd International Conference on Oncopathology & Molecular Oncology, organized by the International Association for Integrated Oncology (IAIO), seeks to convene global experts to advance cancer diagnostics and therapeutics.

Modern Imaging in Early Metastatic Prostate Cancer
Gain insights on advanced imaging techniques for accurate early detection and staging of metastatic prostate cancer.

Castration-Resistant Prostate Cancer Phenotypes
Learn about diverse castration-resistant prostate cancer types and their clinical implications.

Surgical Management of Oligometastatic Prostate Cancer
Exploring surgical options, including palliative procedures for advanced prostate cancer cases.

Therapeutic Updates in Castration-Resistant Prostate Cancer
Reviewing current and emerging treatment modalities for castration-resistant prostate cancer.

Variant Morphologies of Renal Cell Carcinoma
Identifying clinically significant aggressive histologic subtypes of renal cancer.

Surgical Management of Advanced Renal Cancer
Evaluating consolidative and cytoreductive surgical strategies in advanced disease.

Adjuvant Therapy and New Treatments for Advanced Renal Cancer
Discussing the role of adjuvant therapies and novel treatment approaches in advanced renal carcinoma.

Milestones of Oncopathology & Molecular Oncology

Glimpses of Our Conferences

Gallery Gallery Gallery Gallery Gallery Gallery Gallery Gallery Gallery Gallery

What Our Client Says

Why should you attend this International Conference?

Gain Expert Insights
Learn from leading global experts in pathology, oncology, urology, and molecular science.
Stay Updated on Innovations
Discover the latest advancements in cancer diagnostics, molecular profiling, and targeted therapies.
Advance Clinical Practice
Translate emerging research and clinical guidelines into real-world patient care.
Enhance Multidisciplinary Knowledge
Explore integrated perspectives from radiologists, pathologists, urologists, and oncologists for holistic cancer management.
Network with Global Peers
Connect with professionals, researchers, and academicians to foster collaboration and knowledge exchange.
Access Focused Sessions
Deepen your understanding of evolving strategies in the management of genitourinary cancers.

Subscribe To Get Updates